DeepMed Research

VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy

Phase 1

Completed

Conditions: Minimal Hepatic Encephalopathy

Interventions: Biological: Lactobacillus GG
Biological: Placebo

First Posted Date: 2009-10-09

Last Posted Date: 2014-01-07

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 37

Registration Number: NCT00992290

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Pilot Study to Determine the Effectiveness of Antimicrobial Healthcare Worker's (HCW) Hands and Clothing

Not Applicable

Completed

Conditions: Effectiveness of Antimicrobial Impregnated Scrubs in a Healthcare Setting

Interventions: Other: Vestagen scrubs

First Posted Date: 2009-09-03

Last Posted Date: 2016-06-08

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 30

Registration Number: NCT00971373

Locations: 🇺🇸
Virginia Commonwealth University Medical Center, Richmond, Virginia, United States

Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension

Phase 1

Completed

Conditions: Pulmonary Arterial Hypertension

Interventions: Drug: Carvedilol

First Posted Date: 2009-08-25

Last Posted Date: 2017-06-08

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 10

Registration Number: NCT00964678

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Phase 1

Completed

Conditions: Leukemia
Lymphoma

Interventions: Drug: Bortezomib
Drug: Romidepsin

First Posted Date: 2009-08-21

Last Posted Date: 2018-04-23

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 18

Registration Number: NCT00963274

Locations: 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

and more 2 locations

Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy

Phase 2

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Chemotherapeutic Agent Toxicity
Pain
Neurotoxicity
Peripheral Neuropathy

Interventions: Other: questionnaire administration
Other: Sensory Neuropathy Scale instrument
Other: Quality of Life instrument
Device: MC5-A Scrambler device

First Posted Date: 2009-08-06

Last Posted Date: 2017-03-29

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 18

Registration Number: NCT00952848

Evaluating the Acute Effects of Electronic Nicotine Delivery Devices Marketed to Smokers.

Phase 1

Completed

Conditions: Smoking

Interventions: Other: OB
Other: CROWN SEVEN
Other: NJOY
Other: Sham smoking

First Posted Date: 2009-07-03

Last Posted Date: 2016-12-13

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 32

Registration Number: NCT00932295

Locations: 🇺🇸
Clinical Behavioral Pharmacology Laboratory, Richmond, Virginia, United States

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer
Radiation Toxicity

Interventions: Drug: lovastatin
Other: questionnaire administration
Procedure: adjuvant therapy
Radiation: accelerated partial breast irradiation
Radiation: external beam radiation therapy

First Posted Date: 2009-05-15

Last Posted Date: 2013-06-20

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 3

Registration Number: NCT00902668

Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer

Phase 3

Completed

Conditions: Depression
Fatigue
Anxiety Disorder
Breast Cancer
Pain
Sleep Disorders

Interventions: Procedure: energy-based therapy
Procedure: sham intervention

First Posted Date: 2009-05-15

Last Posted Date: 2015-11-23

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 161

Registration Number: NCT00902330

Prevention of Self-care Deterioration in Early Adolescents With Diabetes

Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Behavioral: Diabetes Education
Behavioral: TeamWork CS Sessions

First Posted Date: 2009-04-29

Last Posted Date: 2016-01-08

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 285

Registration Number: NCT00890331

Locations: 🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Pilot Study Evaluating Stress Response and Immune Function in Mechanically Ventilated Patients With Alcohol Use Disorders Treated With Propofol or Midazolam

Phase 4

Withdrawn

Conditions: Respiration, Artificial
Alcoholism

Interventions: Drug: Propofol
Drug: Midazolam

First Posted Date: 2009-03-30

Last Posted Date: 2016-03-01

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT00871039

Locations: 🇺🇸
Virginia Commonwealth University Medical Center (formerly known as Medical College of Virginia), Richmond, Virginia, United States
🇺🇸
Virginia Commonwealth University Medical Center, Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy